ARTICLE | Company News
Paradigm in deals with JNJ, Takeda
July 1, 2005 1:08 AM UTC
Paradigm (Cambridge, U.K.) granted Johnson & Johnson (JNJ) an exclusive license to one of its discovery programs in chronic pain and urinary incontinence. Paradigm will receive upfront research paymen...